Back to Authors

Fawaz, Cherine

A5138359841 | I4210125099

Mayo Clinic

Mayo Clinic in Arizona

Citations 1

Severe Clinical Deterioration Following Plasma Exchange Transition to Subcutaneous Efgartigimod in Refractory CIDP (P1-9.010)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215566